Carlsmed, Inc.
CARLCarlsmed is a commercial-stage medical technology company that provides AI-enabled personalized surgical solutions for spine fusion.
Earnings
Next report
Nov 5, 2026 (in 3 months)Valuation & ratios
Competitors
By market cap
By revenue growth
Profile
Carlsmed is a commercial-stage medical technology company that provides AI-enabled personalized surgical solutions for spine fusion. The company utilizes proprietary algorithms to transform standard diagnostic imaging into patient-specific surgical plans and 3D-printed titanium interbody implants designed to improve spinal alignment and reduce revision surgery rates. Its core value proposition centers on shifting spine surgery from a one-size-fits-all approach with stock implants to a data-driven, personalized standard of care.
Carlsmed is a first-mover in providing commercially available patient-specific interbody technology platforms for lumbar and cervical fusions in the U.S., protected by a robust patent portfolio and a significant data moat of radiographic images.
FAQ
- What is Carlsmed, Inc.'s market cap?
- Carlsmed, Inc. (CARL) has a market capitalization of $377.3M and trades on NASDAQ.
- What is Carlsmed, Inc.'s revenue and profitability?
- Carlsmed, Inc. generated $63.3M in trailing twelve-month revenue with a net loss of $36.3M, representing a net margin of -57.4%. Gross margin stands at 76.6%, with free cash flow of -$34.6M. These figures are based on the Q2 2026 filing.
- Who are Carlsmed, Inc.'s competitors?
- Carlsmed, Inc.'s key competitors include Orthofix Medical Inc., Globus Medical Inc., Alphatec Holdings, Inc., and others. These companies compete in similar markets and product categories.
- Who does Carlsmed, Inc. partner with?
- Carlsmed, Inc.'s notable partners include BioMedGPS, Centers for Medicare and Medicaid Services.
- Where is Carlsmed, Inc. headquartered?
- Carlsmed, Inc. is headquartered in United States of America. It has been publicly traded since 2025.
